Efficacy of Perampanel as a Monotherapy for Seizure Control During Awake Craniotomy in Glioma Patients - Takeaways - MDSpire

Efficacy of Perampanel as a Monotherapy for Seizure Control During Awake Craniotomy in Glioma Patients

  • By

  • Yuta Koketsu

  • Shoichi Deguchi

  • Fumiharu Ohka

  • Kosuke Aoki

  • Yoshiki Shiba

  • Yuhei Takido

  • Shigeaki Nawa

  • Takehito Sato

  • Koichi Akiyama

  • Ryuta Saito

  • April 24, 2026

  • 0 min

Share

  • 1

    Awake craniotomy (AC) allows for extensive glioma resection while minimizing neurological deficits through real-time mapping.

  • 2

    Intraoperative seizures (IOS) during AC can lead to complications, including increased intracranial pressure and neurological deterioration.

  • 3

    The study investigates the efficacy of perampanel (PER) as a monotherapy for preventing IOS during awake craniotomy in glioma patients.

  • 4

    PER was administered at least 3 days prior to surgery, with a dose of 2 mg, and adjusted based on the patient's clinical condition.

  • 5

    The findings aim to clarify the clinical utility of PER monotherapy in reducing intraoperative seizures compared to combination therapies.

Original Source(s)

Related Content